COA availability means a vendor publishes a document or index we can link. It does not mean pepmg certified the product, batch, safety, or authenticity.

● Seven-day market intelligence

The index is a living dataset.

Full change log →

Largest real price drop

BPC-157 ↓56%

~~$9.00~~ → $4.00/mg at Tydes

Widest price spread

20.5×

GLP2 TZ · $1.22–$25.00/mg

New listings

added in the last 7 days

Start with a full dossier

Retatrutide

research, regulatory status, 24 vendors, and source receipts

● The credibility contract

Useful enough to rely on. Honest enough not to push.

Full disclosure →

Ranking is deterministic

Eligible rows sort by normalized $/mg. Affiliate commission is never an input.

Money is visible

Any link that ever pays pepmg is labeled beside the action, and commission never touches ranking. Non-paying rows are always visible too.

Claims carry evidence labels

Human, animal, and in-vitro findings are not collapsed into one vague “research-backed” claim.

Sources keep their limits

A vendor-hosted COA is linked and classified, never promoted as proof of safety or authenticity.

● Weekly market briefing

Follow changes in the price index.

Real repricings, new market floors, and meaningful source changes—without sponsored placements.

One useful email a week · unsubscribe anytime · research use only

Find a peptide.See every price and study.

Field Notes

pepmg found no human trial of 5-amino-1MQ. Its fat-loss and muscle results come from injected mice, in studies by its developer's group.

FDA just approved a myostatin antibody for muscle loss. Every follistatin muscle trial pepmg found delivered a gene, not the protein.

One page, from literature to price comparisons.